Dynamic expression of the main related indicators of thrombosis, inflammatory reaction and tissue damage in a rat model of myocardial infarction

Molecular Medicine Reports

Volumn 4, Issue 4, 2011, Pages 693-696

  Xue, Mei ^a   Yin, Huijun ^a   Zhang, Lu ^a   Guo, Chunyu ^a   Jiang, Yuerong ^a   Wu, Caifeng ^a   Li, Xuefeng ^a   Chen, Keji ^a  

^a XIYUAN HOSPITAL   (China)

Author keywords

Inflammatory reaction; Thrombosis; Tissue damage

Indexed keywords

C REACTIVE PROTEIN; GELATINASE B; INTERLEUKIN 6; PADGEM PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENZYME ACTIVATION; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART INFARCTION; LEFT CORONARY ARTERY; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT;

ANIMALS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DISEASE MODELS, ANIMAL; INFLAMMATION; INTERLEUKIN-6; MALE; MATRIX METALLOPROTEINASE 9; MYOCARDIAL INFARCTION; P-SELECTIN; RATS; RATS, WISTAR; THROMBOSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE PLASMINOGEN ACTIVATOR;

RATTUS; RATTUS NORVEGICUS;

EID: 79957634791     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.485     Document Type: Article

References (19)

1. Yip HK, Chang LT, Sun CK, et al: Platelet activity is a biomarker of cardiac necrosis and predictive of untoward clinical outcomes in patients with acute myocardial infarction undergoing primary coronary stenting. Circ J 70: 31-36, 2006.
2. Liu WH, Yang CH, Yeh KH, et al: Circulating levels of soluble P-selectin in patients in the early and recent phases of myocardial infarction. Chang Gung Med J 28: 613-620, 2005.
3. Ganti AK, Potti A and Yegnanarayan R: Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 levels in acute myocardial infarction. Pathophysiol Haemost Thromb 32: 80-84, 2002. (Pubitemid 37490511)
4. Bian Y, Chen YG, Xu F, Xue L, Ji WQ and Zhang Y: The polymorphism in aldehyde dehydrogenase-2 gene is associated with elevated plasma levels of high-sensitivity C-reactive protein in the early phase of myocardial infarction. Tohoku J Exp Med 221: 107-112, 2010.
5. Kang WQ, Song DL and Guo XG: Relationship between serum vasoactive factors and plaque morphology in patients with acute coronary syndrome. Zhonghua Xin Xue Guan Bing Za Zhi (in Chinese) 35: 1020-1023, 2007.
6. Miyazaki S, Kasai T, Miyauchi K, et al: Changes of matrix metalloproteinase-9 level is associated with left ventricular remodeling following acute myocardial infarction among patients treated with trandolapril, valsartan or both. Circ J 74: 1158-1164, 2010.
7. Dinh W, Füth R, Scheffold T, et al: Increased serum levels of tissue inhibitor of metalloproteinase-1 in patients with acute myocardial infarction. Int Heart J 50: 421-431, 2009.
8. He Y, Shen W, Zhao Y, Yang X, Shao B and Yuan C: The dynamic changes of platelet P-selectin and glycoprotein V in acute myocardial infarction. Suzhou University of Medical Science (in Chinese) 26: 777-779, 2006.
9. Abbate A, Salloum FN, Vecile E, et al: Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental myocardial infarction. Circulation 117: 2670-2683, 2008.
10. Olivetti G, Capasso JM, Meggs LG, Sonnenblick EH and Anversa P: Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Cir Res 68: 856-869, 1991.
11. Chen Z and Gao R: Coronary heart disease. People's Medical Publishing House, Beijing, pp879-882, 2003.
12. Chen KJ, Xue M and Yin HJ: The relationship between platelet activation and coronary heart disease and blood-stasis syndrome. J Capit Med Univ 29: 266-269, 2008.
13. More RS, Underwood MJ, Brack MJ, De Bono DP and Gershlick AH: Changes in vessel wall plasminogen activator activity and smooth muscle cell proliferation and activation after arterial injury. Cardiovasuclar Res 29: 22-26, 1995.
14. Napoleão P, Santos MC, Selas M, Viegas-Crespo AM, Pinheiro T and Ferreira RC: Variations in inflammatory markers in acute myocardial infarction: a longitudinal study. Rev Port Cardiol 26: 1357-1363, 2007. (Pubitemid 351262859)
15. Kishimoto T: Interleukin-6: from basic science to medicine - 40 years in immunology. Annu Rev Immunol 23: 21, 2005.
16. Ding C, Cicuttini F, Li J and Jones G: Targeting IL-6 in the treatment of inflammatory and autoimmune diseases. Expert Opin Investig Drugs 18: 1457-1466, 2009.
17. Kelly D, Squire IB, Khan SQ, et al: Usefulness of plasma tissue inhibitors of metalloproteinases as markers of prognosis after acute myocardial infarction. Am J Cardiol 106: 477-482, 2010.
18. Lowe GD, Danesh J, Lewington S, et al: Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis. Eur Heart J 25: 252-259, 2004.
19. Weir RA, Balmain S, Steedman T, et al: Tissue plasminogen activator antigen predicts medium-term left ventricular endsystolic volume after acute myocardial infarction. J Thromb Thrombolysis 29: 421-428, 2010.